The Clinical Journal of Pain 2002: Vol 18 Index

11 Pages·2002·3.8 MB·English

AUTHOR INDEX 403
Erbay, H. Perquin, C. W., Bertina, W., Hazebroek-Kampschreur, A. A. J. M
Meralgia Paresthetica in Differential Diagnosis of Low-Back Pain. van Suijlekom-Smit, L. W. A.. Koes, B. W.. van der Wouden, J
13 C., Passchier, J.: Stability of Pain Parameters and Pain-Related
Eriksson, M. Y. see Wilson, K. G. Quality of Life in Adolescents With Persistent Pain: A Three
Year Follow-Up, 99
Fanciullo, G. J. see Katz, N.
Ferrell, B. A. see Simmons, S. | Ideguchi, S. see Umino, M
Fialka-Moser, V. see Strauss-Blasche, G Inturrisi, C. f
Finch, P. M. see Roberts, L. J. Clinical Pharmacology of Opioids for Pain, $3
Fishman, S. M.
Kreis, P. G.: The Opioid Contract, $70 Jabbari, B. see Difazio, M
Flickinger, J. C. see Kondziolka, D Jamison, R. N. see Nedeljkovic, S. S
Forouzanfar, T Jamison, R. N
Kemler, M., Kessels, A. G. H., K6ke, A. J. A., van Kleef. M., Introduction, S1
Weber, W. E. J.: Comparison of Multiple Against Single Pain Jasser, S. see Cohen, M. J. M
Intensity Measurements in Complex Regional Pain Syndrome Jensen, M. P. see Galer, B. S
Type I: Analysis of 54 Patients, 234 Jensen, T. S. see Sindrup, S. H
Freund, B. see Schwartz, M Joranson, D. E. see Gilson, A. M
Freund, B. J.
Schwartz, M.: Use of Botulinum Toxin in Chronic Whiplash- Kalizewski, T. see Thimineur, M
Associated Disorder, $163 Kapoor, N
Ciuffreda, K. J.. Tannen, B.: Complex Regional Pain Syndrome
Gagliardi, G. see Ceccherelli, F. Type I: Associated Visual Sensorimotor Case Findings, 93
Gajraj, N. M. see Gatchel, R. J Katz, J. see Bergmans, L
Galer, B. S. Katz, N
Jensen, M. P., Ma, T., Davies, P. S.. Rowbotham, M. C.: The Li Fanciullo, G. J.: Role of Urine Toxicology Testing in the Manage
docaine Patch 5% Effectively Treats All Neuropathic Pain Quali- ment of Chronic Opioid Therapy, $76
ties: Results of a Randomized, Double-Blind, Vehicle-Controlled, Keefe, F. J. see Lefebvre. J. C
3-Week Efficacy Study With Use of the Neuropathic Pain Scale, Kemler, M. see Forouzanfar, 7
297 Kessels, A. G. H. see Forouzanfar, 7
Gatchel, R. J Ketenci, A. see Yiicel, B
Noe, C. E., Pulliam, C., Robbins, H., Deschner, M., Gajraj, N. M.. Kezar, L. see Putzke, J. D
Vakharia, A. S.: A Preliminary Study of Multidimensional Pain Kirsh, K. I
Inventory Profile Differences in Predicting Treatment Outcome in Whitcomb, L. A., Donaghy, K., Passik, S. D.: Abuse and Addiction
a Heterogeneous Cohort of Patients with Chronic Pain, 139 Issues in Medically Ill Patients With Pain: Attempts at Clarifica
Geertzen, J. H. B. see Reinders, M. F. tion of Terms and Empirical Study, $52
Geilen, M. see Vlaeyen, J. W. S. Kitaj, M. see Thimineur, M
Geisser, M. E. see Roth, R. S Koes, B. W. see Hunfeld, J. A. M
Giamberardino, M. A. see Panerai, A. I Kohase, H. see Umino, M
Gilson, A. M Kéke, A. J. A. see Forouzanfar, T
Joranson, D. E.: U.S. Policies Relevant to the Prescribing of Opioid Kollender, Y. see Abraham, R. B
Analgesics for the Treatment of Pain in Patients With Addictive Kondziolka, D
Disease, S91 Lunsford, L. D., Flickinger, J. C.: Stereotactic Radiosurgery for the
Glogau, R. G rreatment of Trigeminal Neuralgia, 42
\ Review of the Use of Botulinum Toxin for Hyperhidrosis and Koot, H. M. see van Dijk, M
Cosmetic Purposes, $191 Kravitz, E. see Thimineur, M
Goodman, J. T. see Ellis, J. A. Kreis, P. G. see Fishman, S. M
Goolkasian, P Kropmans, T. J. B
Wheeler, A. H., Gretz, S. S.: The Neck Pain and Disability Scale Dijkstra, P. U., Stegenga, B., Stewart, R., de Bont, L. G. M.: Re
Test-Retest Reliability and Construct Validity, 245 peated Assessment of Temporomandibular Joint Pain: Reasoned
Gretz, S. S. see Goolkasian, P. Decision-Making With Use of Unidimensional and Multidimen
sional Pain Scales, 107
Halbert. J. Kuo, M.-C. see Chia, Y.-Y
Crotty, M., Cameron, I. D.: Evidence for the Optimal Management
of Acute and Chronic Phantom Pain: A Systematic Review, 84 Lau, J. see Cepeda, M. S
Harding, L. M. see Davies, S. J. Lefebvre. J. C
Hazebroek-Kampschreur, A. A. J. M. see Hunfeld, J. A. M. Keefe, F. J.: Memory for Pain: The Relationshipo f Pain Catastroph
Herron, P. D. see Cohen, M. J. M. izing to the Recall of Daily Rheumatoid Arthritis Pain, 56
Heuts, P. H. T. G. see Vlaeyen, J. W. S Lew, M. I
Hicken, B. L. see Putzke, J. D. Review of the FDA-Approved Uses of Botulinum Toxins, Including
Holmgren, H. see Vrethem, M. Data Suggesting Efficacy in Pain Reduction, $142
Hsieh, S.-W. see Chia, Y.-Y Lindstrém, T. see Vrethem, M
Hunfeld, J. A. M. Liu, K. see Chia, Y.-Y
The Clinical Journal of Pain, Vol. 18, No. 6, 2002
404 AUTHOR INDEX
Loder, E. tions Between Pain, Grip Strength, and Manual Tests in the Treat-
Biondi, D.: Use of Botulinum Toxins for Chronic Headaches: A ment Evaluation of Chronic Tennis Elbow, 164
Focused Review, $169 Pizzigallo, E. see Panerai, A. E.
Lundsford, L. D. see Kondziolka, D. Poudevigne, M. S.
Luskin, M. B. see Morin, C. O’Connor, P. J., Pasley, J. D.: Lack of Both Sex Differences and
Influence of Resting Blood Pressure on Muscle Pain Intensity,
Ma, T. see Galer, B. S. 386
Madsen, H. see Bajaj, P. Price, L. M. see Roberts, L. J.
Malmivaara, A. see Pienimiki, T. Pullan, P. T. see Roberts, L. J.
Margolis, C. G. see Cohen, M. J. M. Pulliam, C. see Gatchel, R. J.
Marktl, W. see Strauss-Blasche, G. Putzke, J. D.
Marouani, N. see Abraham, R. B. Richards, J. S.. Kezar, L., Hicken, B. L., Ness, T. J.: Long-Term Use
Marshall, H. M. see Warms, C. A. of Gabapentin for Treatment of Pain After Traumatic Spinal Cord
Melchart, H. see Strauss-Blasche, G. Injury, 116
Meller, I. see Abraham, R. B.
Rappaport, Z. H. see Devor, M.
Meroni, P. see Panerai, A. E.
Mikail, S. F. see Wilson, K. G. Reed, B. A. see Chapman, S. L.
Reid, C. W. see Ellis, J. A.
Moliner, S. see Cerda-Olmedo, G.
Morin, C. Reinders, M. F.
Geertzen, J. H. B., Dijkstra, P. U.: Complex Regional Pain Syn-
Bushnell, M. C., Luskin, M. B., Craig, A. D. (Bud): Disruption of
Thermal Perception in a Multiple Sclerosis Patient With Central drome Type I: Use of the International Association for the Study
Pain, 191 of Pain Diagnostic Criteria Defined in 1994, 207
Richards, J. S. see Putzke, J. D.
Rigoni, M. T. see Ceccherelli, F.
Nedeljkovic, S. S.
Robbins, H. see Gatchel, R. J.
Wasan, A., Jamison, R. N.: Assessment of Efficacy of Long-Term
Roberts, L. J.
Opioid Therapy in Pain Patients With Substance Abuse Potential,
Finch, P. M., Pullan, P. T., Bhagat, C. I., Price, L. M.: Sex Hormone
$39
Suppression by Intrathecal Opioids: A Prospective Study, 144
Ness, T. J. see Putzke, J. D.
Roth, R. S.
Ng, K. F. J
Geisser, M. E.: Educational Achievement and Chronic Pain Disabil-
Tsui, S. L., Chan, W. S.: Prevalence of Common Chronic Pain in
ity: Mediating Role of Pain-Related Cognitions, 286
Hong Kong Adults, 275
Rowbotham, M. C. see Galer, B. S.
Noe, C. E. see Gatchel, R. J
Royal, M. A. see Smith, H. S.
Nurmikko, T. J. see Peters, G.
Ruzzante, L. see Ceccherelli, F.
Nurmikko, T. J.
Introduction, | Saad. H. H. A. see van Dijk, M.
Sacerdote, P. see Panerai, A. E.
O'Brien, C. F. Sakurai, N. see Umino, M.
Treatment of Spasticity With Botulinum Toxin, $182 Savage, S. R.
O’Connor, B. V. see Ellis, J. A. Assessment for Addiction in Pain-Treatment Settings, $28
O’Connor, P. J. see Poudevigne, M. S. Scarone, S. see Panerai, A. E.
Olsson, I. Schmader, K. E.
Bunketorp, O., Carlsson, S. G., Styf, J.: Prediction of Outcome in Epidemiology and Impact on Quality of Life of Postherpetic Neu-
Whiplash-Associated Disorders Using West Haven—Yale Mullti- ralgia and Painful Diabetic Neuropathy, 350
dimensional Pain Inventory, 238 Schnelle, J. F. see Simmons, S. F.
Ozyalcin, S. see Yiicel, B. Schnoll, S. see Weaver, M.
Schulteis, G. see Wallace. M. S
Panerai, A. E. Schwartz, M. see Freund, B. J.
Vecchiet, J.. Panzeri, P., Meroni, P., Scarone, S., Pizzigallo, E., Schwartz, M.
Giamberardino, M. A., Sacerdote, P.: Peripheral Blood Mono- Freund, B.: Treatment of Temporomandibular Disorders With Botu-
nuclear Cell B-Endorphin Concentration Is Decreased in Chronic linum Toxin, $198
Fatigue Syndrome and Fibromyalgia but Not in Depression: Pre- Sertel, H. O. see Yiicel, B.
liminary Report, 270 Setler, P. F.
Panzeri, P. see Panerai, A. E. Therapeutic Use of Botulinum Toxins: Background and History,
Pasley, J. D. see Poudevigne, M. S. S119
Passchier, J. see Hunfeld, J. A. M. Siira, P. see Pienimiki, T.
Passchier, J. see van Dijk, M. Sim, J.
Passik, S. D. see Kirsh, K. L. Adams, N.: Systematic Review of Randomized Controlled Trials of
Perquin, C. W. see Hunfeld, J. A. M. Nonpharmacological Interventions for Fibromyalgia, 324
Peters, G. Simmons, S. F.
Nurmikko, T. J.: Peripheral and Gasserian Ganglion-Level Proce- Ferrell, B. A., Schnelle, J. F.: Effects of a Controlled Exercise Trial
dures for the Treatment of Trigeminal Neuralgia, 28 on Pain in Nursing Home Residents, 380
Pienimiki, T. Sindrup, S. H.
Tarvainen, T., Siira, P., Malmivaara, A., Vanharanta, H.: Associa- Jensen, T. S.: Pharmacotherapy of Trigeminal Neuralgia, 22
The Clinical Journal of Pain, Vol. 18, No. 6, 2002
AUTHOR INDEX
Smith, H. S. van der Wouden, J. C. see Hunfeld, J. A. M
Audette, J., Royal, M. A.: Botulinum Toxin in Pain Management of van Dijk, M.
Soft Tissue Syndromes, $147 Koot, H. M., Saad, H. H. A., Tibboel, D., Passchier, J.: Observa
Snijdelaar, D. G. see Bergmans, L. tional Visual Analog Scale in Pediatric Pain Assessment: Useful
Sood, P. see Thimineur, M Tool or Good Riddance?, 310
Stegenga, B. see Kropmans, T. J. B. van Kleef, M. see Forouzanfar, T
Stewart, R. see Kropmans, T. J. B van Suijlekom-Smit, L. W. A. see Hunfeld, J. A. M
Strain, E. C. Vanharanta, H. see Pienimiki, 1
Assessment and Treatment of Comorbid Psychiatric Disorders in Vecchiet, J. see Panerai, A. E.
Opioid-Dependent Patients, S14 Viaeyen, J.W .S
Strauss-Blasche, G. de Jong, J., Geilen, M., Heuts, P. H. T. G., van Breukelen. G.: The
Ekmekcioglu, C., Vacariu, G., Melchart, H., Fialka-Moser. V.. Treatment of Fear of Movement/(Re)injury in Chronic Low Back
Marktl, W.: Contribution of Individual Spa Therapies in the Pain: Further Evidence on the Effectiveness of Exposure In Vivo,
Treatment of Chronic Pain, 302 251
Styf, J. see Olsson, I. Vrethem, M
Sun, G.-C. see Chia, Y.-Y. Boivie. J., Arnqvist, H.. Holmgren, H., Lindstrém, T.: Painful Poly
neuropathy in Patients With and Without Diabetes: Clinical, Neu
Talu, G. K. see Yiicel, B. rophysiologic, and Quantitative Sensory Characteristics, 122
Tannen, B. see Kapoor, N
Tarvainen, T. see Pienimiiki. T. Wallace, M. S.
Thimineur, M Braun, J., Schulteis, G.: Postdelivery of Alfentanil and Ketamine
Kitaj, M., Kravitz, E., Kalizewski, T., Sood, P.: Functional Abnor- Has No Effect on Intradermal Capsaicin—Induced Pain and Hy
malities of the Cervical Cord and Lower Medulla and Their Effect peralgesia, 373
on Pain: Observations in Chronic Pain Patients With Incidental Warms, C. A
Mild Chiari | Malformation and Moderate to Severe Cervical Turner, J. A.. Marshall, H. M., Cardenas, D. D.: Treatments for
Cord Compression, 171 Chronic Pain Associated With Spinal Cord Injuries: Many Are
Thompson, D Tried, Few Are Helpful, 154
Toward a Pharmacoeconomic Model of Neuropathic Pain, 366 Wasan, A. see Nedeljkovic, S. S
Tibboel, D. see van Dijk, M. Weaver. M
Tsui, S. L. see Ng, mh. ©. 3. Schnoll, S.: Abuse Liability in Opioid Therapy for Pain Treatment in
Turk, D. C. Patients With an Addiction History, S61
Clinical Effectiveness and Cost-Effectiveness of Treatments for Pa- Weber, W. E. J. see Forouzanfar, 1
tients With Chronic Pain, 355 Weinbroum, A. A. see Abraham, R. B
Turk, D. C. Wheeler, A. H. see Goolkasian, P
Remember the Distinction Between Malignant and Benign Pain? Whitcomb, L. A. see Kirsh, K. I
Well, Forget It, 75 Wilson, K. G
Turner, J. A. see Warms, C. A Eriksson, M. Y., D’Eon, J. L., Mikail, S. F., Emery, P. C.: Major
Depression and Insomnia in Chronic Pain, 77
Umino, M.
Kohase, H., Ideguchi, S., Sakurai, N.: Long-Term Pain Control in Yiicel, B
Trigeminal Neuralgia With Local Anesthetics Using an Indwell- Ozyalcin, S., Sertel, H. O., Camlica, H., Ketenci, A., Talu, G. K
ing Catheter in the Mandibular Nerve, 196 Childhood Traumatic Events and Dissociative Experiences in Pa
tients With Chronic Headache and Low Back Pain, 394
Vacariu, G. see Strauss-Blasche, G
Vakharia, A. S. see Gatchel, R. J. Zakrzewska, J. M.
van Breukelen, G. see Vlaeyen, J. W. S. Diagnosis and Differential Diagnosis of Trigeminal Neuralgia, 14
The Clinical Journal of Pain
18:405-412 © 2002 Lippincott Williams & Wilkins, Inc., Philadelphia
The Clinical Journal of Pain
Volume 18, 2002
Subject Index
Accommodation Therapeutic use of botulinum toxins: Background and history,
Complex regional pain syndrome type I: Associated visual senso- S119
rimotor case findings, 93 Acupuncture
Acetylcholine Comparison of superficial and deep acupuncture in the treatment
Possible mechanisms for the effects of botulinum toxin on pain, of lumbar myofascial pain: A double-blind randomized con-
$125 trolled study, 149
The Clinical Journalo f Pain, Vol. 18, No, 6, 2002
SUBJECT " INDEX
Addiction Blepharospasm
Abuse and addiction issues in medically ill patients with pain: Review of the FDA-approved uses of botulinum toxins, including
Attempts at clarification of terms and empirical study, $52 data suggesting efficacy in pain reduction, $142
Abuse liability in opioid therapy for pain treatment in patients Blood pressure
with an addiction history, S61 Lack of both sex differences and influence of resting blood pres-
Assessment for addiction in pain-treatment settings, $28 sure on muscle pain intensity, 386
Ethical perspectives: Opioid treatment of chronic pain in the con- Book reviews
text of addiction, S99 Acute pain management: A practical guide, 2nd edition, 338
U. S. policies relevant to the prescribing of opioid analgesics for Bonica’s management of pain, 3rd edition, 339
the treatment of pain in patients with addictive disease, S91 Neuropathic pain: Pathophysiology and treatment progress in pain
Addictive opioid-related disorders research and management, Volume 21, 337
Role of urine toxicology testing in the management of chronic Botox
opioid therapy, S76 A focused review of the use of botulinum toxin for low back pain,
Adherence S155
Role of urine toxicology testing in the management of chronic Review of the FDA-approved uses of botulinum toxins, including
opioid therapy, S76
data suggesting efficacy in pain reduction, $142
Adolescents Review of the use of botulinum toxin for hyperhidrosis and cos-
Stability of pain parameters and pain-related quality of life in ado-
metic purposes, S191
lescents with persistent pain: A three-year follow-up, 99
Use of botulinum toxin for chronic headaches: A focused review,
Agreement analysis
S169
Comparison of multiple against single pain intensity measurements
Botulinum toxin
in complex regional pain syndrome type I: Analysis of 54
Botulinum toxin in pain management of soft tissue syndromes,
patients, 234
$147
Alfentanil
Postdelivery of alfentanil and ketamine has no effects on intrader- Considering the immune response to botulinum toxin, $133
mal capsaicin-induced pain and hyperalgesia, 373 A focused review of the use of botulinum toxin for low back pain,
Analgesia S155
Does postoperative pain induce emesis?, 317 A focused review on the use of botulinum toxin for neuropathic
Review of the FDA-approved uses of botulinum toxins, including pain, $177
data suggesting efficacy in pain reduction, $142 Possible mechanisms for the effects of botulinum toxin on pain,
Analgesics $125
Clinical pharmacology of opioids for pain, S3 Review of the FDA-approved uses of botulinum toxins, including
A focused review on the use of botulinum toxin for neuropathic data suggesting efficacy in pain reduction, $142
pain, S177 Review of the use of botulinum toxin for hyperhidrosis and cos-
Role of urine toxicology testing in the management of chronic metic purposes, S19]
opioid therapy, S76 Therapeutic use of botulinum toxins: Background and history,
U. S. policies relevant to the prescribing of opioid analgesics for S119
the treatment of pain in patients with addictive disease, S91 Treatment of spasticity with botulinum toxin, S182
Anticonvulsants Treatment of temporomandibular disorders with botulinum toxin,
Clinical effectiveness and cost-effectiveness of treatments for pa- S198
tients with chronic pain, 355 Use of botulinum toxin for chronic headaches: A focused review,
Antidepressants $169
Clinical effectiveness and cost-effectiveness of treatments for pa- Use of botulinum toxin in chronic whiplash-associated, $163
tients with chronic pain, 355
Anxiety Cancer
The treatment of fear of movement/(re)injury in chronic low back Dextromethorphan for phantom limb pain attenuation in cancer
pain: Evidence on the effectiveness of exposure in vivo, 251] amputees: A double-blind crossover trial involving three pa-
Anxiety disorders tients, 282
Assessment and treatment of comorbid psychiatric disorders in Capsaicin
opioid-dependent patients, S14 Postdelivery of alfentanil and ketamine has no effects on intrader-
Assessment mal capsaicin-induced pain and hyperalgesia, 373
Assessment for addiction in pain-treatment settings, S28 Case report
Assessment of efficacy of long-term opioid therapy in pain pa-
Disruption of thermal perception in a multiple sclerosis patient
tients with substance abuse potential, $39
with central pain, 19]
Effects of controlled exercise trial on pain in nursing home resi-
Long-term pain control in trigeminal neuralgia with local anesthet-
dents, 380
ics using an indwelling catheter in the mandibular nerve, 196
Management of progressive pain in a patient with intramedullary
Back pain chordoma of the spine, 128
Contribution of individual spa therapies in the treatment of Methadone for phantom limb pain, 203
chronic pain, 302 A novel treatment of postherpetic neuralgia using peppermint oil, 200
Balneotherapy Catastrophizing
Contribution of individual spa therapies in the treatment of Memory for pain: The relationship of pain catastrophizing to the
chronic pain, 302 recall of daily rheumatoid arthritis pain, 56
Barriers Causalgia
U. S. policies relevant to the prescribing of opioid analgesics for Defining the therapeutic role of local anesthetic sympathetic
the treatment of pain in patients with addictive disease, S91 blockade in complex regional pain syndrome: A narrative and
6-Endorphin concentration systematic review, 216
Peripheral blood mononuclear cell B-endorphin concentration is Central pain
decreased in chronic fatigue syndrome and fibromyalgia but An overview of neuropathic pain: Syndromes, symptoms, signs,
not in depression: Preliminary report, 270 and several mechanisms, 343
The Clinical Journal of Pain, Vol. 18, No, 6, 2002
SUBJECT INDEX
Disruption of thermal perception in a multiple sclerosis patient Cognition
with central pain, 19] Educational achievement and chronic pain disability: Mediating
Therapeutic extradural cortical stimulation for central and neuro role of pain-related cognitions, 286
pathic pain: A review, 48 Effects of intermediate- and long-term use of opioids on cognition
Cervical cord compression in patients with chronic pain, $83
Functional abnormalities of the cervical cord and lower medulla Cognitive-behavioral treatment
and their effect on pain: Observations in chronic pain patients The treatment of fear of movement/(re)injury in chronic low back
with incidental mild Chiari | malformation and moderate to pain: Evidence on the effectiveness of exposure in vivo, 251
severe cervical cord compression, 171 Cold allodynia
Cervical dystonia Disruption of thermal perception in a multiple sclerosis patient
Review of the FDA-approved uses of botulinum toxins, including with central pain, 191
data suggesting efficacy in pain reduction, $142 Comorbid psychiatric disorders
Cervical pain Assessment and treatment of comorbid psychiatric disorders in
The Neck Pain and Disability Scale: Test-retest reliability and opioid-dependent patients, S14
construct validity, 245 Complex regional pain syndrome
Cervical sprain Comparison of multiple against single pain intensity measurements
in complex regional pain syndrome type I: Analysis of 54
Use of botulinum toxin in chronic whiplash-associated, $163
patients, 234
Chiari | malformation
Complex regional pain syndrome type I: Associated visual senso
Functional abnormalities of the cervical cord and lower medulla
rimotor case findings, 93
and their effect on pain: Observations in chronic pain patients
Complex regional pain syndrome type I: Use of the International
with incidental mild Chiari | malformation and moderate to
Association for the Study of Pain Diagnostic Criteria defined
severe cervical cord compression, 171
in 1994, 207
Childhood abuse
Defining the therapeutic role of local anesthetic sympathetic
Childhood traumatic events and dissociative experiences in pa
blockade in complex regional pain syndrome: A narrative and
tients with chronic headache and low back pain, 394
systematic review, 216
China
A focused review on the use of botulinum toxin for neuropathic
Prevalence of common chronic pain in Hong Kong adults, 2
pain, $177
Chordoma
Functional abnormalities of the cervical cord and lower medulla
Management of progressive pain in a patient with intramedullary
and their effect on pain: Observations in chronic pain patients
chordoma of the spine, 128
with incidental mild Chiari | malformation and moderate to
Chronic fatigue syndrome
severe cervical cord compression, 171
Peripheral blood mononuclear cell 6-endorphin concentration is
Contract
decreased in chronic fatigue syndrome and fibromyalgia but
Phe opioid contract, S70
not in depression: Preliminary report, 270
Cosmetic
Chronic opioid therapy
Review of the use of botulinum toxin for hyperhidrosis and cos
Effects of intermediate- and long-term use of opioids on cognition
metic purposes, S19]
in patients with chronic pain, $83
Cost-effectiveness
The opioid contract, $70
Clinical effectiveness and cost-effectiveness of treatments for pa
Role of urine toxicology testing in the management of chronic
tients with chronic pain, 355
opioid therapy, S76
Toward a pharmacoeconomic model of neuropathic pain, 366
Chronic pain
Cranial nerve neuralgia
Abuse and addiction issues in medically ill patients with pain
Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4
Attempts at clarification of terms and empirical study, S52
\n overview of neuropathic pain: Syndromes, symptoms, signs, Daily pain
and several mechanisms, 343 Memory for pain: The relationship of pain catastrophizing to the
Assessment and treatment of comorbid psychiatric disorders in recall of daily rheumatoid arthritis pain, 56
opioid-dependent patients, S14 Decision-making
Assessment of efficacy of long-term opioid therapy in pain pa- Repeated assessment of temporomandibular joint pain: Reasoned
tients with substance abuse potential, $39 decision-making with use of unidimensional and multidimen
Clinical effectiveness and cost-effectiveness of treatments for pa- sional pain scales, 107
tients with chronic pain, 355 Dementia
Contribution of individual spa therapies in the treatment of Nursing staff members’ perceptions of pain indicators in persons
chronic pain, 302 with severe dementia, 64
Educational achievement and chronic pain disability: Mediating Demyelination
role of pain-related cognitions, 286 Treatment of spasticity with botulinum toxin, $182
Effects of intermediate- and long-term use of opioids on cognition Depression
in patients with chronic pain, $83 Assessment and treatment of comorbid psychiatric disorders in
Major depression and insomnia in chronic pain, 77 opioid-dependent patients, S14
A preliminary study of multidimensional pain inventory profile Major depression and insomnia in chronic pain, 77
differences in predicting treatment outcome in a heteroge Peripheral blood mononuclear cell 6-endorphin concentration 1s
neous cohort of patients with chronic pain, 139 decreased in chronic fatigue syndrome and fibromyalgia but
Prevalence of common chronic pain in Hong Kong adults, 275 not in depression: Preliminary report, 270
Stability of pain parameters and pain-related quality of life in ado- Dextromethorphan
lescents with persistent pain: A three-year follow-up, 99 Dextromethorphan for phantom limb pain attenuation in cancer
Clinical examination amputees: A double-blind crossover trial involving three pa-
Associations between pain, grip strength, and manual tests in the tients, 282
treatment evaluation of chronic tennis elbow, 164 Diabetes
Clinical trial Painful polyneuropathy in patients with and without diabetes:
Long-term use of gabapentin for treatment of pain after traumatic Clinical, neurophysiologic, and quantitative sensory character
spinal cord injury, 116 istics, 122
The Clinical Journalo f Pain, Vol. 18, No. 6, 2002
408 SUBJECT INDEX
Diabetes mellitus Ethics
Epidemiology and impact on quality of life of postherpetic neural- Ethical perspectives: Opioid treatment of chronic pain in the con-
gia and painful diabetic neuropathy, 350 text of addiction, S99
Diabetic neuralgia Euphoria
Epidemiology and impact on quality of life of postherpetic neural- Clinical pharmacology of opioids for pain, $3
gia and painful diabetic neuropathy, 350 Exercise
Diabetic neuropathy Effects of controlled exercise trial on pain in nursing home resi-
An overview of neuropathic pain: Syndromes, symptoms, signs, dents, 380
and several mechanisms, 343 Lack of both sex differences and influence of resting blood pres-
A focused review on the use of botulinum toxin for neuropathic sure on muscle pain intensity, 386
pain, S177 Experimental studies
Diagnosis Postdelivery of alfentanil and ketamine has no effects on intrader-
Diagnosis and differential diagnosis of trigeminal neuralgia, 14 mal capsaicin-induced pain and hyperalgesia, 373
Diagnostic criteria Exposure in vivo
Complex regional pain syndrome type I: Use of the International The treatment of fear of movement/(re)injury in chronic low back
Association for the Study of Pain Diagnostic Criteria defined pain: Evidence on the effectiveness of exposure in vivo, 251
in 1994, 207 Eye movements
Disability measurement Complex regional pain syndrome type I: Associated visual senso-
Educational achievement and chronic pain disability: Mediating rimotor case findings, 93
role of pain-related cognitions, 286
The Neck Pain and Disability Scale: Test-retest reliability and Family
construct validity, 245 Stability of pain parameters and pain-related quality of life in ado-
Dissociative experiences lescents with persistent pain: A three-year follow-up, 99
Childhood traumatic events and dissociative experiences in pa- Fatigue
tients with chronic headache and low back pain, 394 Complex regional pain syndrome type I: Associated visual senso-
Double-blind controlled study rimotor case findings, 93
Comparison of superficial and deep acupuncture in the treatment Fear-avoidance beliefs
of lumbar myofascial pain: A double-blind randomized con- The treatment of fear of movement/(re)injury in chronic low back
trolled study, 149 pain: Evidence on the effectiveness of exposure in vivo, 251
Double-blind crossover study Fibromyalgia
Dextromethorphan for phantom limb pain attenuation in cancer Botulinum toxin in pain management of soft tissue syndromes,
amputees: A double-blind crossover trial involving three pa- S147
tients, 282 Functional abnormalities of the cervical cord and lower medulla
Drug abuse. see Substance abuse and their effect on pain: Observations in chronic pain patients
Drugs with incidental mild Chiari | malformation and moderate to
Pharmacotherapy of trigeminal neuralgia, 22 severe cervical cord compression, 171
Drug-seeking behavior Peripheral blood mononuclear cell 8-endorphin concentration is
Abuse liability in opioid therapy for pain treatment in patients decreased in chronic fatigue syndrome and fibromyalgia but
with an addiction history, S61 not in depression: Preliminary report, 270
Dystonia Systematic review of randomized controlled trials of nonpharma-
Botulinum toxin in pain management of soft tissue syndromes, cological interventions for fibromyalgia, 324
$147 Follow-up
Possible mechanisms for the effects of botulinum toxin on pain, Stability of pain parameters and pain-related quality of life in ado-
$125 lescents with persistent pain: A three-year follow-up, 99
Therapeutic use of botulinum toxins: Background and history, Functional capacity
S119 Associations between pain, grip strength, and manual tests in the
treatment evaluation of chronic tennis elbow, 164
Economics Gabapentin
Toward a pharmacoeconomic model of neuropathic pain, 366 Long-term use of gabapentin for treatment of pain after traumatic
Editorials spinal cord injury, 116
Remember the distinction between malignant and benign pain? Gender
Well, forget it, 75 Lack of both sex differences and influence of resting blood pres-
Educational attainment sure on muscle pain intensity, 386
Educational achievement and chronic pain disability: Mediating Generalizability
role of pain-related cognitions, 286 Repeated assessment of temporomandibular joint pain: Reasoned
Efficacy decision-making with use of unidimensional and multidimen-
Pharmacotherapy of trigeminal neuralgia, 22 sional pain scales, 107
Elderly Grip strength
Nursing staff members’ perceptions of pain indicators in persons Associations between pain, grip strength, and manual tests in the
with severe dementia, 64 treatment evaluation of chronic tennis elbow, 164
Emesis
Does postoperative pain induce emesis?, 317 Headache
Endogenous opioid Childhood traumatic events and dissociative experiences in pa-
Clinical pharmacology of opioids for pain, S3 tients with chronic headache and low back pain, 394
Epidural anesthesia Use of botulinum toxin for chronic headaches: A focused review,
Evidence for the optimal management of acute and chronic phan- S169
tom pain: A systematic review, 84 Heat
Errata A comparison of modality-specific somatosensory changes during
Therapeutic extradural cortical stimulation for central and neuro- menstruation in dysmenorrheic and nondysmenorrheic
pathic pain: A review, 195 women, 180
The Clinical Journal of Pain, Vol. 18, No. 6, 2002
SUBJECT " INDEX
Hemifacial spasm Letters to the editor
Review of the FDA-approved uses of botulinum toxins, including A comparison of blacks and whites seeking treatment for chronic
data suggesting efficacy in pain reduction, $142 pain, 136
Herniated disc Lidocaine patch
A focused review of the use of botulinum toxin for low back pain The lidocaine patch 5% effectively treats all neuropathic pain
S155 qualities: Results of a randomized, double-blind, vehicle-con-
Herpes zoster trolled, 3-week efficacy study with use of the Neuropathic
Epidemiology and impact on quality of life of postherpetic neural- Pain Scale, 297
gia and painful diabetic neuropathy, 350 Local anesthetics
Human clinical trial Long-term pain control in trigeminal neuralgia with local anesthet-
Comparison of superficial and deep acupuncture in the treatment ics using an indwelling catheter in the mandibular nerve, 196
of lumbar myofascial pain: A double-blind randomized con- Long-term pain control
trolled study, 149 Long-term pain control in trigeminal neuralgia with local anesthet
Hyperhidrosis ics using an indwelling catheter in the mandibular nerve, 196
Review of the use of botulinum toxin for hyperhidrosis and cos- Low back pain
metic purposes, S19] Childhood traumatic events and dissociative experiences in pa-
Hypogonadism tients with chronic headache and low back pain, 394
Sex hormone suppression by intrathecal opioids: A prospective Comparison of superficial and deep acupuncture in the treatment
study, 144 of lumbar myofascial pain: A double-blind randomized con
Hypothalamic-pituitary-gonadal axis trolled study, 149
Sex hormone suppression by intrathecal opioids: A prospective A focused review of the use of botulinum toxin for low back pain
study, 144 Si55
Meralgia paresthetica in differential diagnosis of low-back pain,
Immune response 132
Considering the immune response to botulinum toxin, $133 The treatment of fear of movement/(re)injury in chronic low back
Immune system pain: Evidence on the effectiveness of exposure in vivo, 251
Peripheral blood mononuclear cell B-endorphin concentration is
decreased in chronic fatigue syndrome and fibromyalgia but Magnetic resonance imaging
not in depression: Preliminary report, 270 Diagnosis and differential diagnosis of trigeminal neuralgia, 14
Immunogenicity Mandibular nerve
Considering the immune response to botulinum toxin, $133 Long-term pain control in trigeminal neuralgia with local anesthet-
Impairment ics using an indwelling catheter in the mandibular nerve, 196
Associations between pain, grip strength, and manual tests in the McGill Pain Questionnaire
treatment evaluation of chronic tennis elbow, 164 A comparison of modality-specific somatosensory changes during
Implantable drug delivery systems menstruation in dysmenorrheic and nondysmenorrheic
Clinical effectiveness and cost-effectiveness of treatments for pa women, 180
tients with chronic pain, 355 Medical decision-making
Indwelling catheter Ethical perspectives: Opioid treatment of chronic pain in the con
Long-term pain control in trigeminal neuralgia with local anesthet- text of addiction, S99
ics using an indwelling catheter in the mandibular nerve, 196 Medical illness
Insomnia Abuse and addiction issues in medically ill patients with pain:
Major depression and insomnia in chronic pain, 7 Attempts at clarification of terms and empirical study, $52
Interdisciplinary treatment Medication misuse/abuse
A preliminary study of multidimensional pain inventory profile Abuse liability in opioid therapy for pain treatment in patients
differences in predicting treatment outcome in a heteroge- with an addiction history, S61
neous cohort of patients with chronic pain, 139 Memory for pain
International Association for the Study of Pain Memory for pain: The relationship of pain catastrophizing to the
Complex regional pain syndrome type I: Use of the International recall of daily rheumatoid arthritis pain, 56
Association for the Study of Pain Diagnostic Criteria defined Menstrual pain
in 1994, 207 A comparison of modality-specific somatosensory changes during
Interviews menstruation in dysmenorrheic and nondysmenorrheic women
Stability of pain parameters and pain-related quality of life in ado- Menthol
lescents with persistent pain: A three-year follow-up, 99 \ novel treatment of postherpetic neuralgia using peppermint oil,
Intractable behavior 200
Role of urine toxicology testing in the management of chronic Meralgia paresthetica
opioid therapy, S76 Meralgia paresthetica in differential diagnosis of low-back pain, 132
Intraspinal opioids Meta-analysis
Sex hormone suppression by intrathecal opioids: A prospective Defining the therapeutic role of local anesthetic sympathetic
study, 144 blockade in complex regional pain syndrome: A narrative and
Intraventricular approach systematic review, 216
Management of progressive pain in a patient with intramedullary Methadone
chordoma of the spine, 128 Methadone for phantom limb pain, 203
Methodology
Ketamine Comparison of superficial and deep acupuncture in the treatment
Postdelivery of alfentanil and ketamine has no effects on intrader- of lumbar myofascial pain: A double-blind randomized con-
mal capsaicin-induced pain and hyperalgesia, 373 trolled study, 149
N-Methyl-D-aspartate
Lateral epicondylitis Dextromethorphan for phantom limb pain attenuation in cancer
Associations between pain, grip strength, and manual tests in the amputees: A double-blind crossover trial involving three pa-
treatment evaluation of chronic tennis elbow, 164 tients, 282
The Clinical Journal of Pain, Vol. 18, No. 6, 2002
SUBJECT * INDEX
Microvascular decompression A novel treatment of postherpetic neuralgia using peppermint oil,
Microvascular decompression, 35 200
Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4 Peripheral and Gasserian ganglion-level procedures for the treat-
Modeling ment of trigeminal neuralgia, 28
Toward a pharmacoeconomic model of neuropathic pain, 366 Therapeutic extradural cortical stimulation for central and neuro-
Morphine pathic pain: A review, 48
Does postoperative pain induce emesis?, 317 Toward a pharmacoeconomic model of neuropathic pain, 366
Effects of intermediate- and long-term use of opioids on cognition Neuropathic Pain Scale
in patients with chronic pain, S83 The lidocaine patch 5% effectively treats all neuropathic pain
Sex hormone suppression by intrathecal opioids: A prospective qualities: Results of a randomized, double-blind, vehicle-con-
study, 144 trolled, 3-week efficacy study with use of the Neuropathic
Morphinelike agonist Pain Scale, 297
Clinical pharmacology of opioids for pain, S3 Neurotoxin
Motor cortex stimulation Possible mechanisms for the effects of botulinum toxin on pain,
Therapeutic extradural cortical stimulation for central and neuro- $125
pathic pain: A review, 48 Therapeutic use of botulinum toxins: Background and history,
Multidimensional Pain Inventory S119
Prediction of outcome in whiplash-associated disorders using West Nociceptive pain
Haven-Yale Multidimensional Pain Inventory, 238 A focused review on the use of botulinum toxin for neuropathic
A preliminary study of multidimensional pain inventory profile pain, S177
differences in predicting treatment outcome in a heteroge- Nociceptor
neous cohort of patients with chronic pain, 139 A focused review of the use of botulinum toxin for low back pain,
Multiple pain rating $155
Comparison of multiple against single pain intensity measurements Nonpharmacological treatment
in complex regional pain syndrome type I: Analysis of 54 Systematic review of randomized controlled trials of nonpharma-
patients, 234 cological interventions for fibromyalgia, 324
Multiple sclerosis Nursing homes
Disruption of thermal perception in a multiple sclerosis patient Effects of controlled exercise trial on pain in nursing home resi
with central pain, 19] dents, 380
Muscle pain Nursing staff members’ perceptions of pain indicators in persons
Lack of both sex differences and influence of resting blood pres- with severe dementia, 64
sure on muscle pain intensity, 386
Myobloc
A focused review of the use of botulinum toxin for low back pain, Opioid dependence
S155 Assessment and treatment of comorbid psychiatric disorders in
Review of the FDA-approved uses of botulinum toxins, including opioid-dependent patients, S14
data suggesting efficacy in pain reduction, $142 Opioid pain
Review of the use of botulinum toxin for hyperhidrosis and cos- Role of urine toxicology testing in the management of chronic
metic purposes, $19] opioid therapy, S76
Use of botulinum toxin for chronic headaches: A focused review, Opioid receptor
$169 Clinical pharmacology of opioids for pain, S3
Myofascial pain Opioid rotation
Comparison of superficial and deep acupuncture in the treatment Clinical pharmacology of opioids for pain, S3
of lumbar myofascial pain: A double-blind randomized con- Opioids
trolled study, 149 Assessment for addiction in pain-treatment settings, S28
Assessment of efficacy of long-term opioid therapy in pain pa-
Neck pain tients with substance abuse potential, S39
The Neck Pain and Disability Scale: Test-retest reliability and Clinical effectiveness and cost-effectiveness of treatments for pa-
construct validity, 245 tients with chronic pain, 355
Prediction of outcome in whiplash-associated disorders using West Effects of intermediate- and long-term use of opioids on cognition
Haven-Yale Multidimensional Pain Inventory, 238 in patients with chronic pain, S83
Use of botulinum toxin in chronic whiplash-associated, $163 The opioid contract, $70
Nerve blocks U. S. policies relevant to the prescribing of opioid analgesics for
Evidence for the optimal management of acute and chronic phan- the treatment of pain in patients with addictive disease, S91
tom pain: A systematic review, 84 Orofacial pain
Nerve pathophysiology Treatment of temporomandibular disorders with botulinum toxin,
Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4 $198
Neural pathways Outcome evaluation
Treatment of spasticity with botulinum toxin, $182 Assessment of efficacy of long-term opioid therapy in pain pa-
Neurontin tients with substance abuse potential, $39
Long-term use of gabapentin for treatment of pain after traumatic
spinal cord injury, 116
Neuropathic pain Pain
An overview of neuropathic pain: Syndromes, symptoms, signs, Effects of controlled exercise trial on pain in nursing home resi-
and several mechanisms, 343 dents, 380
A focused review on the use of botulinum toxin for neuropathic Nursing staff members’ perceptions of pain indicators in persons
pain, S177 with severe dementia, 64
The lidocaine patch 5% effectively treats all neuropathic pain Possible mechanisms for the effects of botulinum toxin on pain,
qualities: Results of a randomized, double-blind, vehicle-con- $125
trolled, 3-week efficacy study with use of the Neuropathic Review of the FDA-approved uses of botulinum toxins, including
Pain Scale, 297 data suggesting efficacy in pain reduction, $142
The Clinical Journal of Pain, Vol. 18, No. 6, 2002
SUBJECT INDEX
Therapeutic use of botulinum toxins: Background and history, Policy
S119 U. S. policies relevant to the prescribing of opioid analgesics for
Treatments for chronic pain associated with spinal cord injuries the treatment of pain in patients with addictive disease, $91
Many are tried, few are helpful, 154 Polyneuropathy
Use of botulinum toxin for chronic headaches: A focused review, Painful polyneuropathy in patients with and without diabetes
S169 Clinical, neurophysiologic, and quantitative sensory character
Pain beliefs istics, 122
Educational achievement and chronic pain disability: Mediating Population
role of pain-related cognitions, 286 Prevalence of common chronic pain in Hong Kong adults, 275
Pain management Postherpetic neuralgia
The lidocaine patch 5% effectively treats all neuropathic pain An overview of neuropathic pain: Syndromes, symptoms, signs,
qualities: Results of a randomized, double-blind, vehicle-con- and several mechanisms, 343
trolled, 3-week efficacy study with use of the Neuropathic Epidemiology and impact on quality of life of postherpetic neural
Pain Scale, 297 gia and painful diabetic neuropathy, 350
Pain in hospitalized pediatric patients: How are we doing?, 262 \ focused review on the use of botulinum toxin for neuropathic
U. S. policies relevant to the prescribing of opioid analgesics for pain, $177
the treatment of pain in patients with addictive disease, S91 The lidocaine patch 5% effectively treats all neuropathic pain
Pain measurement qualities: Results of a randomized, double-blind, vehicle-con-
The Neck Pain and Disability Scale: Test-retest reliability and trolled, 3-week efficacy study with use of the Neuropathic
construct validity, 245 Pain Scale, 297
Pain mechanism \ novel treatment of postherpetic neuralgia using peppermint oil,
200
The lidocaine patch 5% effectively treats all neuropathic pain
Postoperative pain
qualities: Results of a randomized, double-blind, vehicle-con-
Does postoperative pain induce emesis?, 317
trolled, 3-week efficacy study with use of the Neuropathic
Pain Scale, 297 Pressure
Pain-patient heterogeneity \ comparison of modality-specific somatosensory changes during
A preliminary study of multidimensional pain inventory profile menstruation in dysmenorrheic and nondysmenorrheic women
Prevalence
differences in predicting treatment outcome in a heteroge-
neous cohort of patients with chronic pain, 139 Prevalence of common chronic pain in Hong Kong adults, 275
Pain prevalence Principle of double effect
Pain in hospitalized pediatric patients: How are we doing?, Ethical perspectives: Opioid treatment of chronic pain in the con
text of addiction, S99
262
Pain rating index Pseudoaddiction
Abuse liability in opioid therapy for pain treatment ia patients
Repeated assessment of temporomandibular joint pain: Reasoned
with an addiction history, S61
decision-making with use of unidimensional and multidimen-
sional pain scales, 107 Ethical perspectives: Opioid treatment of chronic pain in the con
text of addiction, $99
Pain rehabilitation program
Psychometrics
Clinical effectiveness and cost-effectiveness of treatments for pa
Observational visual analog scale in pediatric pain assessment
tients with chronic pain, 355
Pain threshold Useful tool or good riddance?, 310
Prediction of outcome in whiplash-associated disorders using West
Associations between pain, grip strength, and manual tests in the
treatment evaluation of chronic tennis elbow, 164 Haven-Yale Multidimensional Pain Inventory, 238
Psychomotor tasks
Patient-controlled analgesia
Effects of intermediate- and long-term use of opioids on cognition
Does postoperative pain induce emesis?, 317
Pediatric pain in patients with chronic pain, $83
Observational visual analog scale in pediatric pain assessment: Quality of life
Useful tool or good riddance?, 310 Contribution of individual spa therapies in the treatment of
Pain in hospitalized pediatric patients: How are we doing?, 262 chronic pain, 302
Peppermint Epidemiology and impact on quality of life of postherpetic neural
A novel treatment of postherpetic neuralgia using peppermint oil, gia and painful diabetic neuropathy, 350
200 Ethical perspectives: Opioid treatment of chronic pain in the con-
Peripheral blood mononuclear cells text of addiction, $99
Peripheral blood mononuclear cell B-endorphin concentration is Stability of pain parameters and pain-related quality of life in ado-
decreased in chronic fatigue syndrome and fibromyalgia but lescents with persistent pain: A three-year follow-up, 99
not in depression: Preliminary report, 270
Personality disorders Radiosurgery
Assessment and treatment of comorbid psychiatric disorders in Stereotactic radiosurgery for the treatment of trigeminal neuralgia,
opioid-dependent patients, $14 42
Phantom limb pain Randomized controlled trials
Dextromethorphan for phantom limb pain attenuation in cancer Systematic review of randomized controlled trials of nonpharma-
amputees: A double-blind crossover trial involving three pa- cological interventions for fibromyalgia, 324
tients, 282 Reflex sympathetic dystrophy
Evidence for the optimal management of acute and chronic phan- Complex regional pain syndrome type I: Associated visual senso-
tom pain: A systematic review, 84 rimotor case findings, 93
Methadone for phantom limb pain, 203 Defining the therapeutic role of local anesthetic sympathetic
Pharmacoeconomic model blockade in complex regional pain syndrome A narrative and
Toward a pharmacoeconomic model of neuropathic pain, 366 systematic review, 216
Physical therapy Rehabilitation
Contribution of individual spa therapies in the treatment of Associations between pain, grip strength, and manual tests in the
chronic pain, 302 treatment evaluation of chronic tennis elbow, 164
The Clinical Journalo f Pain, Vol. 18, No. 6, 2002
412 SUBJECT INDEX
Reliability Survey
Repeated assessment of temporomandibular joint pain: Reasoned Treatments for chronic pain associated with spinal cord injuries:
decision-making with use of unidimensional and multidimen- Many are tried, few are helpful, 154
sional pain scales, 107 Systematic review
Review Complex regional pain syndrome type I: Use of the International
Peripheral and Gasserian ganglion-level procedures for the treat- Association for the Study of Pain Diagnostic Criteria defined
ment of trigeminal neuralgia, 28 in 1994, 207
Rheumatoid arthritis Systematic review of randomized controlled trials of nonpharma-
Memory for pain: The relationship of pain catastrophizing to the cological interventions for fibromyalgia, 324
recall of daily rheumatoid arthritis pain, 56
Telephone survey
Prevalence of common chronic pain in Hong Kong adults, 275
Secondary nonresponsiveness Temporomandibular disorders
Considering the immune response to botulinum toxin, $133 Repeated assessment of temporomandibular joint pain: Reasoned
Sensitivity decision-making with use of unidimensional and multidimen-
A comparison of modality-specific somatosensory changes during sional pain scales, 107
menstruation in dysmenorrheic and nondysmenorrheic women Treatment of temporomandibular disorders with botulinum toxin,
Sensory examination $198
Painful polyneuropathy in patients with and without diabetes: Temporomandibular joint
Clinical, neurophysiologic, and quantitative sensory character- Treatment of temporomandibular disorders with botulinum toxin,
istics, 122 $198
Single pain rating Testosterone
Comparison of multiple against single pain intensity measurements Sex hormone suppression by intrathecal opioids: A prospective
in complex regional pain syndrome type I: Analysis of 54 study, 144
patients, 234 Thermosensory
Sleep Disruption of thermal perception in a multiple sclerosis patient
Major depression and insomnia in chronic pain, 77 with central pain, 191
Socioeconomic status Tic douloureux
Educational achievement and chronic pain disability: Mediating Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4
role of pain-related cognitions, 286 Treatment
Soft-tissue syndromes A novel treatment of postherpetic neuralgia using peppermint oil,
Botulinum toxin in pain management of soft tissue syndromes, 200
$147 Peripheral and Gasserian ganglion-level procedures for the treat-
Somatosensory threshold ment of trigeminal neuralgia, 28
A comparison of modality-specific somatosensory changes during Treatments for chronic pain associated with spinal cord injuries:
menstruation in dysmenorrheic and nondysmenorrheic women Many are tried, few are helpful, 154
Spasticity Trigeminal nerve
Treatment of spasticity with botulinum toxin, $182 Stereotactic radiosurgery for the treatment of trigeminal neuralgia,
Spa therapy 42
Contribution of individual spa therapies in the treatment of Trigeminal neuralgia
chronic pain, 302 Diagnosis and differential diagnosis of trigeminal neuralgia, 14
Spinal cord injury Long-term pain control in trigeminal neuralgia with local anesthet-
A focused review on the use of botulinum toxin for neuropathic ics using an indwelling catheter in the mandibular nerve, 196
pain, S177 Microvascular decompression, 35
Long-term use of gabapentin for treatment of pain after traumatic Pathophysiology of trigeminal neuralgia: The ignition hypothesis, 4
spinal cord injury, 116 Peripheral and Gasserian ganglion-level procedures for the treat-
Treatments for chronic pain associated with spinal cord injuries: ment of trigeminal neuralgia, 28
Many are tried, few are helpful, 154 Pharmacotherapy of trigeminal neuralgia, 22
Spinal cord stimulation Stereotactic radiosurgery for the treatment of trigeminal neuralgia,
Clinical effectiveness and cost-effectiveness of treatments for pa- 42
tients with chronic pain, 355
Spinal tumors Urine toxicology testing
Management of progressive pain in a patient with intramedullary Role of urine toxicology testing in the management of chronic
chordoma of the spine, 128 opioid therapy, S76
Spinothalamic tract
Visual analog scale
Disruption of thermal perception in a multiple sclerosis patient
Observational visual analog scale in pediatric pain assessment:
with central pain, 191
Useful tool or good riddance?, 310
Strabismus
Repeated assessment of temporomandibular joint pain: Reasoned
Review of the FDA-approved uses of botulinum toxins, including
decision-making with use of unidimensional and multidimen-
data suggesting efficacy in pain reduction, $142 sional pain scales, 107
Substance abuse
Abuse and addiction issues in medically ill patients with pain: Weight lifting
Attempts at clarification of terms and empirical study, $52 Lack of both sex differences and influence of resting blood pres-
Abuse liability in opioid therapy for pain treatment in patients sure on muscle pain intensity, 386
with an addiction history, S61 Whiplash
Assessment for addiction in pain-treatment settings, $28 Prediction of outcome in whiplash-associated disorders using West
Assessment of efficacy of long-term opioid therapy in pain pa- Haven-Yale Multidimensional Pain Inventory, 238
tients with substance abuse potential, $39 Use of botulinum toxin in chronic whiplash-associated, $163
The opioid contract, S70 Whiplash-associated disorders
Surgery Use of botulinum toxin in chronic whiplash-associated
Microvascular decompression, 35 disorders, $163
The Clinical Journal of Pain, Vol. 18, No. 6, 2002